Hospital Universitari VHIO - Vall d'Hebron Departamento de Oncologia

Barcelona 08035

0 studies enrolling now · 1 studies all time

What they study most

Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma

Studies at this site

• CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma — Completed